Loading
One dose of HPV vaccine protects as well as two or three. Halving the doses frees supply to vaccinate far more girls, boys and young adults.
One dose of HPV vaccine protects as well as two or three, so this idea coordinates a switch to single-dose schedules in every country and directs the freed supply to gender-neutral and catch-up vaccination to age 26. KEN SHE and other trials showed single-dose efficacy and WHO recommends one- or two-dose schedules, yet many countries retain two doses; in low-income countries supply and delivery cost rather than hesitancy are the main limits, and a single dose halves both. Progress would be measured by coverage in Gavi-supported countries and HPV16/18 prevalence in 18-year-olds. The test is country-level monitoring as the switch is implemented. Being tested at scale, it addresses the bottlenecks Prevention we already have is not deployed and Most of the world has almost no cancer care.
Shares International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination, Cervical cancer.
Shares Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Prevention we already have is not deployed, Most of the world has almost no cancer care.
Shares International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed, Head and neck squamous cell carcinoma.